[PDF] Top 20 Informe N°6 Laboratorio de Física II UNMSM
Has 10000 "Informe N°6 Laboratorio de Física II UNMSM" found on our website. Below are the top 20 most common "Informe N°6 Laboratorio de Física II UNMSM".
PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery
... of idiopathic pulmonary fibrosis (IPF), diagnosis and management of the condition continue to pose significant ...of Fibrosis in the Lung Clinical Endpoints) study is a currently enrolling, ... See full document
10
Fernandez, Isis E. (2018): Biomarker discovery and drug testing in Idiopathic Pulmonary Fibrosis. Dissertation, LMU München: Medizinische Fakultät
... in idiopathic pulmonary fibrosis (IPF) primarily relies on lung function ...bleomycin-induced pulmonary fibrosis in ...of fibrosis was observed at day 14, whereas lung function ... See full document
13
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study
... the discovery and validation cohorts were predominantly male (78.3% discovery, ...the discovery cohort had baseline FVC data and 76 had 12-month FVC measurements ...the discovery and ... See full document
23
Pathways in pulmonary arterial hypertension: the future is here
... and fibroblasts [50]. As a potent mitogen, PDGF exerts its effects via two receptor tyrosine kinases: PDGFR- a and PDGFR- b [51]. Evidence suggesting a role for PDGF in the pathophysiology of PAH implies that inhibition ... See full document
97
Physiology of the lung in idiopathic pulmonary fibrosis
... Because IPF typically affects older patients and smokers, multiple comorbidities can affect patients with IPF [100, 101]. In particular, chronic obstructive pulmonary disease (COPD) and pulmonary emphysema ... See full document
9
Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease
... IPAH: idiopathic pulmonary arterial hypertension; NSCLC: nonsmall cell lung cancer; IPF: idiopathic pulmonary fibrosis; HPS: Hermansky – Pudlak syndrome; PVR: pulmonary vascular ... See full document
22
Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis
... FIGURE 3. Alveolar lymphangiogenesis is a feature of idiopathic pulmonary fibrosis (IPF). a) Tissue sections reacted with anti-D2-40 (brown) and anti-CD34 (red) antibodies. Lymphatic vessels (D2-40+; ... See full document
43
Temporal echocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib with or without oxygen therapy
... mean pulmonary artery systolic pressure (PASP) changes after nintedanib treatment in idiopathic pulmonary fibrosis (IPF) patients with (solid line) and without (dotted line) long-term oxygen ... See full document
38
Coagulation and anticoagulation in idiopathic pulmonary fibrosis
... et al. [29] reported increased platelet–monocyte interactions (a sensitive marker of platelet activation) in patients with IPF compared with non-IPF interstitial lung disease (ILD) and non-ILD controls. Platelets are ... See full document
26
Managing comorbidities in idiopathic pulmonary fibrosis
... IPF patients diagnosed with lung cancer are frequently not candidates for curative therapy given the low functional capacity in this population and decreased ability to tolerate cancer therapies. Management of lung ... See full document
7
Pirfenidone treatment of idiopathic pulmonary fibrosis
... Pirfenidone is an intriguing new drug for the treatment of IPF, with approval in Japan and further sales in India. A wide variety of effects on cells has made understanding the mode of action difficult, and further ... See full document
19
Pulmonary hypertension and chronic lung disease: where are we headed?
... induce pulmonary dysfunction changing the expression and the activity of connexion 43, a transmembrane protein involved in the gap junction on the cell membrane, allowing the transfer of signalling molecules ... See full document
74
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
... of fibrosis in IPF patients using high resolution computed tomography (HRCT), with both visual scoring by a radiologist and computer-aided analysis, over 1 year in clinical ... See full document
44
Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis
... Defective proteostasis. The efficiency of proteostasis declines with age in parallel to defective translation, missense mutations, and oxidative modification. Changes in proteostasis lead to an increase of nonfunctional ... See full document
6
Collagen polymorphism in idiopathic chronic pulmonary fibrosis
... Carboxymethylcellulose and agarose chromatography of both types I and III collagens, and amino acid and carbohydrate analyses of the resulting a-chains indicated that the alI, a2, and al[r] ... See full document
27
The therapy of idiopathic pulmonary fibrosis: what is next?
... ABSTRACT Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung disease, characterised by progressive scarring of the lung and associated with a high burden of ... See full document
71
Lung transplantation in chronic obstructive pulmonary disease: patient selection and special considerations
... Patients with COPD receive less priority under the current LAS, therefore patients who are transplanted likely represent a population with more advanced disease, as opposed to before the implementation of the LAS. ... See full document
15
Original Article Identification of key genes associated with idiopathic pulmonary fibrosis using bioinformatics analysis
... IPF [34]. Increased syndecan-1 (which is encoded by SDC1) have been detected in lung homogenates and lavage fluid of lungs in patients with IPF, and syndecan-1 ectodo- main induces neutrophil chemotax- is, inhibits wound ... See full document
143
Epidemiology of idiopathic pulmonary fibrosis
... Abstract: Idiopathic pulmonary fibrosis is a chronic fibrotic lung disease of unknown cause that occurs in adults and has a poor prognosis. Its epidemiology has been difficult to study because of its ... See full document
12
Staging of idiopathic pulmonary fibrosis
... Staging of IPF is useful for physicians and patients. Traditionally, clinical, radiographic, and physiologic (CRP) scoring system for IPF was proposed (42). High CRP score correlated significantly with the total ... See full document
16
Related subjects